1. Home
  2. HRL vs VTRS Comparison

HRL vs VTRS Comparison

Compare HRL & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$23.09

Market Cap

12.9B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$12.75

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRL
VTRS
Founded
1891
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
14.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HRL
VTRS
Price
$23.09
$12.75
Analyst Decision
Buy
Hold
Analyst Count
6
6
Target Price
$28.00
$11.50
AVG Volume (30 Days)
4.6M
8.6M
Earning Date
02-26-2026
02-26-2026
Dividend Yield
5.12%
3.81%
EPS Growth
N/A
N/A
EPS
0.87
N/A
Revenue
$12,106,160,000.00
$14,124,400,000.00
Revenue This Year
$3.42
N/A
Revenue Next Year
$2.24
$1.18
P/E Ratio
$26.31
N/A
Revenue Growth
1.55
N/A
52 Week Low
$21.03
$6.85
52 Week High
$32.07
$12.73

Technical Indicators

Market Signals
Indicator
HRL
VTRS
Relative Strength Index (RSI) 45.25 77.18
Support Level $22.24 $12.19
Resistance Level $23.22 $12.68
Average True Range (ATR) 0.42 0.25
MACD -0.16 0.00
Stochastic Oscillator 39.10 95.10

Price Performance

Historical Comparison
HRL
VTRS

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: